Approval · Notice of Compliance 3614 · 2003
KETEK: Notice of Compliance 3614
Issued May 28, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3614
- Date
- May 28, 2003
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KETEK | 02247520 | Cancelled Post Market |
Medicinal ingredients
- TELITHROMYCIN 400 MG per TAB